Frontiers in Stem Cells & Regeneration


Course Information

Course Date: October 8 – October 14, 2017

Deadline: June 20, 2017 | Apply here

Tuition: $3150.00
Room and Board: $421.50
Financial Assistance Available: Yes

2016 Schedule (PDF)

Contact for more information:

Directors: Jennifer Morgan, MBL; and Gerald P. Schatten, University of Pittsburgh

Course Description

The Frontiers in Stem Cells and Regeneration Course is a laboratory and lecture based course that includes a complete array of biological and medical perspectives from fundamental basic biology of “stemness” and mechanisms of regeneration through evaluation of pluripotent stem cells for therapeutic benefit. This dynamic, evolving course features world class lectures from experts in stem cells and regeneration biology, including a keynote Pioneer Lecture delivered by a leading expert. The laboratories explore a variety of timely topics including stem cell derivation, pluripotency, directed differentiation, and spinal cord and limb regeneration, using an array of experimental models ranging from planarians to human stem cells.

The NIH sponsored course is designed for graduate students, postdoctoral fellows, newly independent scientists, and established investigators seeking comprehensive and sophisticated training in research strategies and state-of-the-art cellular, molecular and genetic approaches for advancing stem cell and regeneration research.

The course also features bioethics seminars, career coaching, and ongoing one-on-one mentoring by course faculty participants.

The Stem Cells and Regeneration Course will exclusively use human embryonic stem cell lines on the NIH Human Embryonic Stem Cell Registry and being routinely cultured at the Pittsburgh Development Center.

2016 Course Faculty & Lecturers

Eli Adashi, Brown University
Arturo Alvarez-Buylla, UCSF
Ona Bloom, Feinstein Institute
Susan Bryant, University of California, Irvine
Diane Carlisle, University of Pittsburgh
Chad Cowan, Harvard Stem Cell Institute
Ina Dobrinski, University of Calgary
Charles Easley, Emory University School of Medicine
David Forsthoefel, OMRF
Elaine Fuchs, Rockefeller University / HHMI
Jose Garcia Arraras, University of Puerto Rico
David Gardiner, University of California, Irvine
David Hyde, Notre Dame University
Mark Hughes, Genesis Genetics Institute
Jongwhan Kim, University of Texas-Austin
Mark Krasnow, Stanford
Leslie Leinwand, University of Colorado, Boulder
Michael Levin, Tufts University
Malcolm Maden, University of Florida
Alexander Meissner, Harvard Stem Cell Institute
Maya Mitalipova, MIT
James Monaghan, Northeastern University
Jennifer Morgan, MBL
Ken Muneoka, Texas A&M
Andras Nagy, Lunenfeld-Tanenbaum Research Institute, Toronto
Phil Newmark, Univ. of Ill. Urbana-Champaign / HHMI
Kyle Orwig, University of Pittsburgh
Pasquale Patrizio, Yale University School of Medicine
Jan Pruszak, University of Freiburg
Ravi Ravindranath, NIH/NICHD
Tobias Schatton, Brigham and Women’s Hospital
Jerry Shay, University of Texas-Southwestern
Calvin Simerly, University of Pittsburgh
Henk ten Have, Duquesne University
Jonathan Tilly, Northeastern University
Ava Udvadia, University of Wisconsin Milwaukee
S. Randal Voss, University of Kentucky
Amittha Wickrema, UChicago
Hunt Willard, MBL
Leonard Zon, Harvard / HHMI